Search

everythinglearnresearchcommunity

for

Search:↓

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

Women with AGA have higher lipid levels, increasing heart disease risk.

Women with hair loss have more androgen receptors in certain hair follicles.

Scarring hair loss found in female pattern; biopsy needed for diagnosis.

Traction alopecia is common and preventable, especially among Indian women.

Minoxidil and botulinum toxin are equally effective for treating female hair loss.

Microbial imbalances in hair follicles may contribute to hair loss, especially in women.

Both minoxidil-spironolactone and minoxidil-finasteride treatments work for hair loss, but minoxidil-spironolactone is slightly more effective, especially in women.

Men with a family history of hair loss on their mother's side are more likely to have female pattern hair loss.

Women with hair loss have higher androgen levels, while men with early balding have altered androgen ratios.

Women with hair loss may benefit from higher iron levels.

Topical finasteride is promising for hair loss with minimal side effects but needs more research and approval.

Women with androgenetic alopecia may have higher blood pressure levels.

Women with androgenetic alopecia have normal levels of most blood steroids and binding proteins, but higher dehydroepiandrosterone. Some also have low "sex hormone-binding globulin" and "corticosteroide-binding globulin" capacity, and high "free androgen index" and "free cortisol index". Diane treatment can normalize these levels and improve hair conditions.

Women with androgenetic alopecia often have other symptoms of high androgen levels, requiring further hormone testing.

Women with a certain type of hair loss have more copper in the back of their head than the front, and treatment can normalize hair but not copper levels.

Women with androgenetic alopecia have noticeable changes in their autonomic nervous system.

Women with androgenetic alopecia have lower SHBG levels.

Hair loss doesn't affect COVID-19 severity.

The document concludes that hair loss and acne in women can be due to both androgen-related and unrelated causes, requiring a collaborative treatment approach.

The treatment slightly increased hair growth and was safe for most women.

Women of reproductive age with polycystic ovary syndrome often experience hair loss.

More severe hair loss is linked to more sexual dysfunction in both men and women.

Finasteride and dutasteride effectively treat hair loss, with dutasteride showing slightly better results.

Finasteride and dutasteride effectively treat hair loss, with dutasteride showing slightly better results.

Diffuse alopecia in females is often linked to certain medications, diseases, and low hemoglobin, while female pattern hair loss is linked to age, duration, and family history.

Most women with long-term, widespread hair loss need a tissue examination for an accurate diagnosis.

Women with severe acne, hirsutism, and androgenic alopecia often have higher levels of certain androgens, but the specific pattern can't be predicted just by looking at symptoms.

Women with acne and hair loss, even if they have regular periods, often have polycystic ovary syndrome.

The combination of hair follicle stem cells and PRP shows promise for treating hair loss in Asian men and women.